FibroBiologics, Inc. — Form C-AR (Regulation Crowdfunding)
FibroBiologics, Inc. of Houston, TX filed a Form C-AR (Regulation Crowdfunding) with the SEC on 2023-05-01.
Offering
- Filed: 2023-05-01
- Form: C-AR
- Accession: 0001193125-23-130251
Issuer
- CIK: 0001958777
- Website: www.fibrobiologics.com
- Legal status: Corporation
- Organized in: DE
- Incorporated: 2021-12-14
- Address: 455 E. Medical Center Blvd Suite 300, Houston, TX, 77598
- Employees: 7
Financials (as filed)
- Total assets (most recent): $4.8M
- Cash (most recent): $2.3M
- Net income (most recent): $-5.1M
- Net income (prior): $-1.6M
- Short-term debt: $7.1M
- Long-term debt: $1.7M
People (7)
| Name | Role | Location |
|---|
| Matthew Link | Director | Houston, TX |
| Stacy Coen | Director | Houston, TX |
| Victoria Niklas | Director | Houston, TX |
| Richard Cilento | Director | Toronto, A6 |
| Peter O'Heeron | Chairman/Founder/CEO | Tucson, AZ |
| Peter O'Heeron | President, CEO and Chairman of the Board | Tucson, AZ |
| Mark Andersen | CFO | Houston, TX |
Reg CF filing history (5)
More